JP2022510346A5 - - Google Patents
Info
- Publication number
- JP2022510346A5 JP2022510346A5 JP2021531369A JP2021531369A JP2022510346A5 JP 2022510346 A5 JP2022510346 A5 JP 2022510346A5 JP 2021531369 A JP2021531369 A JP 2021531369A JP 2021531369 A JP2021531369 A JP 2021531369A JP 2022510346 A5 JP2022510346 A5 JP 2022510346A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl
- group
- carbon atoms
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1819399.5 | 2018-11-28 | ||
| GB1819399.5A GB2579253A (en) | 2018-11-28 | 2018-11-28 | Antibacterial antisense agents |
| PCT/GB2019/053354 WO2020109792A1 (en) | 2018-11-28 | 2019-11-27 | Antibacterial antisense agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022510346A JP2022510346A (ja) | 2022-01-26 |
| JP2022510346A5 true JP2022510346A5 (https=) | 2022-11-09 |
Family
ID=65024582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531369A Pending JP2022510346A (ja) | 2018-11-28 | 2019-11-27 | 抗菌アンチセンス剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220106595A1 (https=) |
| EP (1) | EP3887520A1 (https=) |
| JP (1) | JP2022510346A (https=) |
| KR (1) | KR20210098493A (https=) |
| CN (1) | CN113366107A (https=) |
| AU (1) | AU2019386368A1 (https=) |
| CA (1) | CA3121064A1 (https=) |
| GB (1) | GB2579253A (https=) |
| WO (1) | WO2020109792A1 (https=) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54130516A (en) * | 1978-03-31 | 1979-10-09 | Yuuichi Yamamura | Acyllnnacetylmuramylpeptide derivativeeantigen combination |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| EP0541486A1 (de) | 1991-11-07 | 1993-05-12 | Ciba-Geigy Ag | Polycyclische Konjugate |
| WO2006104530A1 (en) * | 2005-03-28 | 2006-10-05 | Cell Works Therapeutics, Inc. | Therapeutics targeted to renal cells |
| US20140073589A1 (en) | 2012-06-27 | 2014-03-13 | Shire Ag | Amphetamine Prodrugs |
| EP3564374A1 (en) * | 2013-06-21 | 2019-11-06 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulation of target nucleic acids |
| WO2015006740A2 (en) * | 2013-07-11 | 2015-01-15 | Alnylam Pharmaceuticals, Inc. | Oligonucleotide-ligand conjugates and process for their preparation |
| EP2845607A1 (en) | 2013-09-09 | 2015-03-11 | University of Vienna | Antisense oligonucleotides with improved pharmacokinetic properties |
| CA2948373A1 (en) | 2014-05-16 | 2015-11-19 | Oregon State University | Antisense antibacterial compounds and methods |
| CA2948568A1 (en) | 2014-05-19 | 2015-11-26 | David Greenberg | Antisense antibacterial compounds and methods |
| EP3240794A4 (en) | 2014-12-31 | 2018-10-31 | Oregon State University | Antisense antibacterial compounds and methods |
| WO2016172615A1 (en) | 2015-04-24 | 2016-10-27 | University Of Delaware | Synthetic n-acetyl-muramic acid derivatives and uses thereof |
| WO2017010575A1 (ja) * | 2015-07-16 | 2017-01-19 | 協和発酵キリン株式会社 | β２ＧＰＩ遺伝子発現抑制核酸複合体 |
| US11142764B2 (en) | 2015-12-23 | 2021-10-12 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| AU2016379399B2 (en) | 2015-12-23 | 2022-12-08 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| US11180756B2 (en) * | 2017-03-09 | 2021-11-23 | Ionis Pharmaceuticals | Morpholino modified oligomeric compounds |
-
2018
- 2018-11-28 GB GB1819399.5A patent/GB2579253A/en not_active Withdrawn
-
2019
- 2019-11-27 KR KR1020217019995A patent/KR20210098493A/ko not_active Ceased
- 2019-11-27 JP JP2021531369A patent/JP2022510346A/ja active Pending
- 2019-11-27 WO PCT/GB2019/053354 patent/WO2020109792A1/en not_active Ceased
- 2019-11-27 AU AU2019386368A patent/AU2019386368A1/en not_active Abandoned
- 2019-11-27 CA CA3121064A patent/CA3121064A1/en active Pending
- 2019-11-27 CN CN201980090482.5A patent/CN113366107A/zh active Pending
- 2019-11-27 EP EP19816851.0A patent/EP3887520A1/en not_active Withdrawn
- 2019-11-27 US US17/296,748 patent/US20220106595A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7008056B2 (ja) | 修飾されたサブユニット間結合および／または末端基を有するオリゴヌクレオチドアナログ | |
| JP7792371B2 (ja) | ＧａｌＮＡｃ誘導体 | |
| CN103619356B (zh) | 肽寡核苷酸缀合物 | |
| CN100400045C (zh) | 基于核酸的化合物及其使用方法 | |
| JP2020176141A (ja) | 機能的に修飾されたオリゴヌクレオチドおよびそのサブユニット | |
| RU2481346C2 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| JP2009523777A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2016529324A5 (https=) | ||
| IL165715A (en) | 2-ureido-6-heteroaryl-3h-benzimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| JP2005533061A5 (https=) | ||
| EP1033992A1 (en) | Rnase l activators and antisense oligonucleotides effective to treat rsv infections | |
| JP2005533824A5 (https=) | ||
| JP2004537517A5 (https=) | ||
| JP2006518197A5 (https=) | ||
| WO2004074270A3 (en) | Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same | |
| JP2024511954A5 (https=) | ||
| JP2024533371A5 (https=) | ||
| RU2450015C2 (ru) | Производные аминотиазола и их применение в качестве антибактериальных средств | |
| JP2022040131A5 (https=) | ||
| JP2011517697A5 (https=) | ||
| JP2022544538A5 (https=) | ||
| JP2022510346A5 (https=) | ||
| JP2010518016A5 (https=) | ||
| JP2022509763A5 (https=) |